Literature DB >> 24107849

IgG4-related kidney disease.

Takako Saeki1, Mitsuhiro Kawano2.   

Abstract

IgG4-related kidney disease (IgG4-RKD) is a comprehensive term for renal lesions associated with IgG4-related disease, which is a recently recognized clinical entity characterized by a dense lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells with fibrosis affecting several organs. Tubulointerstitial nephritis with increased IgG4-positive plasma cells and fibrosis is the most dominant feature of IgG4-RKD and may cause acute or chronic renal dysfunction, although some glomerular lesions such as membranous nephropathy are sometimes evident. Radiologically, several characteristic abnormalities are often demonstrated, sometimes mimicking malignancies. IgG4-RKD predominantly affects middle-aged to elderly men, and most patients have accompanying IgG4-related extrarenal lesions such as sialadenitis, lymphadenopathy, or type 1 autoimmune pancreatitis. Serology usually demonstrates high levels of serum total IgG and IgG4, and high levels of serum IgE and hypocomplementemia are also frequent features. Corticosteroid therapy is usually quite effective, leading to amelioration of the renal dysfunction and radiological and serological abnormalities. However, as any delay in treatment may result in irreversible renal failure, early diagnosis and appropriate therapy are very important. Despite these distinctive clinicopathological features of IgG4-RKD, its pathogenesis remains poorly understood. Awareness of this condition and accumulation of more cases worldwide are necessary.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24107849     DOI: 10.1038/ki.2013.393

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  46 in total

1.  IgG4-related disease associated with renal microaneurysms and polycythaemia.

Authors:  François-Xavier Danlos; Fadela Daoued-Keffi; Julien Rohmer; Guillaume Cluzel; Estelle Blanc-Autran; Hélène François; Thierry Lazure; Raphaele Seror; Xavier Mariette
Journal:  Rheumatology (Oxford)       Date:  2015-10-13       Impact factor: 7.580

Review 2.  IgG4-related disease: what urologists should know.

Authors:  Daniele Bianchi
Journal:  Int Urol Nephrol       Date:  2016-01-02       Impact factor: 2.370

3.  Predictors of disease relapse in IgG4-related disease following rituximab.

Authors:  Zachary S Wallace; Hamid Mattoo; Vinay S Mahajan; Maria Kulikova; Leo Lu; Vikram Deshpande; Hyon K Choi; Shiv Pillai; John H Stone
Journal:  Rheumatology (Oxford)       Date:  2016-02-16       Impact factor: 7.580

Review 4.  IgG4-related renal disease: clinical and pathological characteristics.

Authors:  Naoto Kuroda; Tomoya Nao; Hideo Fukuhara; Takashi Karashima; Keiji Inoue; Yoshinori Taniguchi; Mai Takeuchi; Yoh Zen; Yasuharu Sato; Kenji Notohara; Tadashi Yoshino
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

5.  Inflammatory Pseudotumour of Kidney: a Manifestation of IgG4 Disease.

Authors:  Somendra Bansal; Rajiv Yadav; Shalu Gupta
Journal:  Indian J Surg Oncol       Date:  2020-07-13

6.  Anti-mitochondria antibody-related tubulointerstitial nephritis accompanied by severe hypokalemic paralysis.

Authors:  Masashi Morita; Yoshito Yamaguchi; Satoshi Masuyama; Jun Nakamura; Sachio Kajimoto; Ryota Haga; Yu Yamanouchi; Katsuyuki Nagatoya; Hideaki Miwa; Atsushi Yamauchi
Journal:  CEN Case Rep       Date:  2019-01-14

Review 7.  IgG4-related nephropathy.

Authors:  Giacomo Quattrocchio; Dario Roccatello
Journal:  J Nephrol       Date:  2016-03-14       Impact factor: 3.902

8.  Up-to date of glomerular disease.

Authors:  Cristiana Rollino
Journal:  J Nephrol       Date:  2016-07-02       Impact factor: 3.902

Review 9.  IgG4-related autoimmune diseases: Polymorphous presentation complicates diagnosis and treatment.

Authors:  Alexander Kleger; Thomas Seufferlein; Martin Wagner; Andrea Tannapfel; Thomas K Hoffmann; Julia Mayerle
Journal:  Dtsch Arztebl Int       Date:  2015-02-20       Impact factor: 5.594

10.  IgG4 and IgE co-positive group found in idiopathic orbital inflammatory disease.

Authors:  Peng-Xiang Zhao; Yao Mawulikplimi Adzavon; Jian-Min Ma; Lei Shang; Dan-Ying Chen; Fei Xie; Meng-Yu Liu; Xin Zhang; Bao-Bei Lyu; Ming-Zi Zhang; Lin-Qi Yang; Xue-Mei Ma
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.